Literature DB >> 1700345

Formic acid treatment exposes hidden neurofilament and tau epitopes in abnormal cytoskeletal filaments from patients with progressive supranuclear palsy and Alzheimer's disease.

S Cammarata1, G Mancardi, M Tabaton.   

Abstract

In cases of progressive supranuclear palsy (PSP) and Alzheimer's disease (AD) the treatment of tissue sections with formic acid (FA) disclosed a neurofilament epitope in subcortical straight (SF) and paired helical (PHF) filaments. The same treatment produced a two-fold increase of tau-reactive neuropil threads and plaque-related neurites in AD cortical tissue. These findings indicate that epitopes of cytoskeletal proteins are hidden by the beta-pleated conformation of SF and PHF components. FA treatment should be used in immunohistochemical detection of intraneuronal abnormal cytoskeletal filaments.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700345     DOI: 10.1016/0304-3940(90)90481-n

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.

Authors:  A D Snow; R T Sekiguchi; D Nochlin; R N Kalaria; K Kimata
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

2.  Immunohistochemical and histopathologic correlates of Alzheimer's disease-associated Alz-50 immunoreactivity quantified in homogenates of cerebral tissue.

Authors:  S M de la Monte; R A Spratt; J Chong; H A Ghanbari; J R Wands
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.